End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.8 NZD | -3.45% | -6.67% | -20.00% |
May. 01 | AFT Pharmaceuticals Signs Brazil Licensing Agreement for Maxigesic IV | MT |
Apr. 24 | New Zealand Shares Rise on US Earnings Rally; AFT Pharmaceuticals to Develop Topical Scar Treatment | MT |
Evolution of the average Target Price on AFT Pharmaceuticals Limited
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AFT Stock
- Consensus AFT Pharmaceuticals Limited